Kang, YK
264  Ergebnisse:
Personensuche X
?
 
?
3

Ramosetron for the Prevention of Cisplatin-Induced Acute Em..:

Kang, YK ; Park, YH ; Ryoo, BY...
Journal of International Medical Research.  30 (2002)  3 - p. 220-229 , 2002
 
?
 
?
7

Avapritinib Versus Regorafenib in Locally Advanced Unresect..:

Kang, Y-K ; George, S ; Jones, RL...
Journal of Clinical Oncology, 2021, 39 (28), pp. 3128 - 3139.  , 2022
 
?
 
?
9

Ripretinib Versus Sunitinib in Patients With Advanced Gastr..:

Bauer, S ; Jones, RL ; Blay, J-Y...
Journal of Clinical Oncology, 2022, pp. JCO2200294 -.  , 2022
 
?
10

Diagnosis and management of tropomyosin receptor kinase (TR..:

Demetri, GD ; Antonescu, CR ; Bjerkehagen, B...
Annals of oncology : official journal of the European Society for Medical Oncology, 2020, 31 (11), pp. 1506 - 1517.  , 2021
 
?
11

Avapritinib in unresectable or metastatic PDGFRA D842V-muta..:

Jones, RL ; Serrano, C ; von Mehren, M...
Jones , RL , Serrano , C , von Mehren , M , George , S , Heinrich , MC , Kang , YK , Schöffski , P , Cassier , PA , Mir , O , Chawla , SP , Eskens , F , Rutkowski , P , Tap , WD , Zhou , T , Roche , M & Bauer , S 2021 , ' Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial ' , European Journal of Cancer , vol. 145 , pp. 132-142 . https://doi.org/10.1016/j.ejca.2020.12.008.  , 2021
 
?
12

Avapritinib in unresectable or metastatic PDGFRA D842V-muta..:

Jones, RL ; Serrano, C ; von Mehren, M...
European journal of cancer (Oxford, England : 1990), 2021, 145 pp. 132 - 142.  , 2021
 
?
13

Diagnosis and management of tropomyosin receptor kinase (TR..:

Demetri, G D ; C R, Antonescu ; Bjerkehagen, B...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.annonc.2020.08.2232.  , 2020
 
1-15